Technology News and Research

RSS

First Edition: February 13, 2012

Today's early morning highlights from the major news organizations preview President Barack Obama's budget, which will be released today, and examine the lingering controversy over mandates on contraceptive coverage.

13 Feb 2012

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Regeneron Pharmaceuticals, Inc. announced financial and operating results for the fourth quarter and full year 2011 and provided an update on development programs.

13 Feb 2012

OncoSec to commence OMS ElectroImmunotherapy Phase II trial in MCC

OncoSec Medical Incorporated, which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that physicians at the University of Washington and Seattle Cancer Care Alliance in conjunction with the Fred Hutchinson Cancer Center, have treated several patients in an open-label Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the treatment of Merkel cell carcinoma.

13 Feb 2012

New method can create scaffolds for tissue engineering applications

Researchers at Northwestern University have developed a new method for creating scaffolds for tissue engineering applications, providing an alternative that is more flexible and less time-intensive than current technology.

13 Feb 2012

Helmet fit, air bladder lining may be linked with concussion and intracranial hemorrhage

Concussions and the issues that can occur following one, continue to be a serious problem for football players. However, one simple game strategy: proper helmet fit, may be one of the easiest game winners for prevention, say researchers presenting their study at the American Orthopaedic Society for Sports Medicine's Specialty Day in San Francisco.

13 Feb 2012

Research team studies effect of anabolic steroids on body fat

A research team at Luleå University of Technology and Umea University has, in a unique study involving ten Swedish elite lifters who are actively using anabolic steroids, studied the effect of Anabolic steroids on body fat. Swedish elite lifters who use anabolic steroids have more dangerous fat distribution in the body.

12 Feb 2012

Web-based tool suite helps first responders rapidly coordinate resources during disasters

A Web-based tool suite that helps first responders rapidly coordinate resources during disasters, co-sponsored by the Office of Naval Research (ONR), is being introduced at a University of Connecticut panel Feb. 8-11 as part of a month-long rollout.

10 Feb 2012

Automated insulin pump delivery can reduce hypoglycemia in individuals with type 1 diabetes

An automated on/off feature built into insulin pump systems can suspend insulin delivery when it detects low blood glucose levels (via continuous glucose monitoring), significantly reducing the severity and duration of hypoglycemia in individuals with type 1 diabetes, according to a study published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc.

10 Feb 2012

VTT develops new NFC-based applications for visually impaired

As the proportion of senior citizens grows, their special needs are gaining momentum. Human eyesight, for example, weakens with age. VTT Technical Research Centre of Finland has been developing new NFC-based applications that make life easier for the visually impaired.

10 Feb 2012

Water and sanitation sector must speak up to be included in NTD eradication efforts

Applauding the signing of the so-called "London Declaration on NTDs" by a consortium of public and private partners last week, Ned Breslin, CEO of Water For People, writes in this Huffington Post "Impact" opinion piece, "I am saddened by the emphasis on vaccines and medicines as the seemingly only vehicles to eradicate NTDs by London Declaration signatories. And I wonder where water, sanitation and hygiene are in this mix, as by all accounts it is not anywhere to be seen in the NTD eradication initiative."

10 Feb 2012

Gene therapy to promote remyelination in mouse model of MS

Our bodies are full of tiny superheroes-antibodies that fight foreign invaders, cells that regenerate, and structures that ensure our systems run smoothly. One such structure is myelin-a material that forms a protective, insulating cape around the axons of our nerve cells so that they can send signals quickly and efficiently. But myelin, and the specialized cells called oligodendrocytes that make it, become damaged in demyelinating diseases like multiple sclerosis (MS), leaving neurons without their myelin sheaths.

10 Feb 2012

Administration officials announce new initiatives to promote innovations in global development

In a White House briefing on Wednesday, "senior Administration officials announced a series of new initiatives to promote game-changing innovations to solve long-standing development challenges" in response to President Obama's "call to harness science technology, and innovation to spark global development," Gayle Smith, special assistant to the president, and Tom Kalil, senior adviser for science, technology, and innovation, write in this post in the White House Blog.

10 Feb 2012

States' capabilities to share patient data vary greatly

According to a Brookings Institution study, the development of state health information exchanges has been slowed by governance, financing and policy issues.

10 Feb 2012

International Congress on Nursing Informatics to be held June 23-27

Informatics leaders, practitioners and other members of the healthcare community will convene June 23-27, 2012, in Montreal, Canada, for the 11th International Congress on Nursing Informatics (NI2012). The Congress gives participants from across the world a forum to discuss the impact of informatics on patient care improvement, global health, professional practice, health policy and research.

10 Feb 2012

SomaLogic to receive TB biomarkers grant from Gates Foundation

SomaLogic, Inc., announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative that seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.

10 Feb 2012

New cERD method can detect RNAi activity in biological fluids

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its scientists have discovered a novel method for monitoring RNAi activity in blood samples, representing a potential major advance for future development of RNAi therapeutics, other therapeutic modalities, and diagnostics.

10 Feb 2012

New approach for production of tissue culture scaffolds in 3-D arrangements

Scientists at the University of California, San Diego have developed a new method for making scaffolds for culturing tissue in three-dimensional arrangements that mimic those in the body. This advance, published online in the journal Advanced Materials, allows the production of tissue culture scaffolds containing multiple structurally and chemically distinct layers using common laboratory reagents and materials.

10 Feb 2012

New device offers fresh hope for patients with Motor Neurone Disease

Patients suffering from a devastating disease are being given fresh hope through an innovative trial being led by the Sheffield Institute for Translational Neuroscience (SITraN) and Sheffield Teaching Hospitals.

10 Feb 2012

Smith & Nephew introduces POLARCUP Dual Mobility Hip System

Smith & Nephew, the global medical technology business, is introducing the clinically proven POLARCUP Dual Mobility Hip System to orthopaedic surgeons in the US at this year's American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Francisco.

10 Feb 2012

Parkinson’s disease gene - parkin explored: Study

Researchers at the University at Buffalo have discovered how mutations in the parkin gene cause Parkinson's disease, which afflicts at least 500,000 Americans and for which there is no cure. The results are published in the current issue of Nature Communications.

9 Feb 2012